References

Quantitative magnetic resonance imaging for biological image-guided adaptive radiotherapy

10.3389/fonc.2020.615643 · 2021 · External reference

ADC measurements on the Unity MR-linac - a recommendation on behalf of the Elekta Unity MR-linac consortium

10.1016/j.radonc.2020.09.046 · 2020 · External reference

Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator

10.1016/j.mri.2024.03.020 · 2024 · External reference

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study

10.2478/raon-2023-0020 · 2023 · External reference

Daily intravoxel incoherent motion (IVIM) In prostate cancer patients during MR-guided radiotherapy-a multicenter study

10.3389/fonc.2021.705964 · 2021 · External reference

Distortion-free diffusion MRI using an MRI-guided Tri-Cobalt 60 radiotherapy system: sequence verification and preliminary clinical experience

10.1002/mp.12465 · 2017 · External reference

Imaging biomarker roadmap for cancer studies

10.1038/nrclinonc.2016.162 · 2017 · External reference

Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group

10.1016/j.ejca.2021.04.041 · 2021 · External reference

The role of diffusion-weighted MRI in biological image-guided radiation therapy: a roadmap

10.1088/1361-6560/ae5d80 · 2026 · External reference

Prospective image Quality and Lesion Assessment in the setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: a Comparison to a Standard 3 T MRI

10.3390/cancers13071533 · 2021 · External reference

Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner

10.1016/j.radonc.2023.110046 · 2024 · External reference

Prostate cancer: a correlative study of multiparametric MR imaging and digital histopathology

10.1148/radiol.2017160906 · 2017 · External reference

Changes in epithelium, stroma, and lumen space correlate more strongly with gleason pattern and are stronger predictors of prostate ADC changes than cellularity metrics

10.1148/radiol.2015142414 · 2015 · External reference

Primary endpoint analysis of the phase 2 DESTINATION-MRL trial for patients with intermediate-risk prostate cancer

10.1016/j.ijrobp.2025.11.028 · 2025 · External reference

Functional MRI for radiotherapy dose painting

10.1016/j.mri.2012.04.010 · 2012 · External reference

Quantitative imaging for radiotherapy purposes

10.1016/j.radonc.2020.01.026 · 2020 · External reference

Image guidance in radiation therapy for better cure of cancer

10.1002/1878-0261.12751 · 2020 · External reference

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations

10.1593/neo.81328 · 2009 · External reference

Dipy, a library for the analysis of diffusion MRI data

10.3389/fninf.2014.00008 · 2014 · External reference

Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans

10.1088/0031-9155/50/7/017 · 2005 · External reference

MRI-visible liquid crystal thermometer

10.1002/mrm.28224 · 2020 · External reference

Spin diffusion measurements: spin echoes in the presence of a time‐dependent field gradient

10.1063/1.1695690 · 1965 · External reference

A biomimetic tumor tissue phantom for validating diffusion-weighted MRI measurements

10.1002/mrm.27016 · 2018 · External reference

Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging

10.1097/rli.0000000000000115 · 2015 · External reference

Improved magnetic resonance imaging-pathology correlation with imaging-derived, 3D-printed, patient-specific whole-mount molds of the prostate

10.1097/rli.0000000000000372 · 2017 · External reference

10.3322/caac.21388

10.3322/caac.21388 · External reference

Measurement error proportional to the mean

10.1136/bmj.313.7049.106 · 1996 · External reference

Applications of the repeatability of quantitative imaging biomarkers: a review of statistical analysis of repeat data sets

10.1593/tlo.09268 · 2009 · External reference

Understanding bland altman analysis

10.11613/bm.2015.015 · 2015 · External reference

Multiparametric magnetic resonance imaging of the prostate: repeatability of volume and apparent diffusion coefficient quantification

10.1097/rli.0000000000000382 · 2017 · External reference

Anatomical zone and tissue type impacts the repeatability of quantitative MRI parameters and radiomic features for longitudinal monitoring of treatment response in the prostate

10.1007/s10334-025-01231-9 · 2025 · External reference

Repeatability and reproducibility assessment of the apparent diffusion coefficient in the prostate: a trial of the ECOG-ACRIN Research Group (ACRIN 6701)

10.1002/jmri.28093 · 2022 · External reference

Effect of inaccurate b-values from imaging gradients on intravoxel incoherent motion

10.1002/mrm.30579 · 2025 · External reference

Dose intensification to the dominant intraprostatic lesion during prostate stereotactic body radiation therapy delivered on a magnetic resonance imaging linear accelerator: feasibility and early clinical outcomes

2025 · External reference

Correlation between ADC, ADC ratio, and Gleason Grade group in prostate cancer patients undergoing radical prostatectomy: retrospective multicenter study with different MRI scanners

10.3389/fonc.2023.1079040 · 2023 · External reference

Comparative evaluation of ADC and ADC ratio in differentiating Gleason score 7 in prostate cancer imaging

10.1016/j.ejro.2025.100710 · 2025 · External reference

Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy

10.2214/ajr.10.4441 · 2011 · External reference

Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature

10.21037/gs.2019.05.02 · 2019 · External reference

Prostate cancer

10.1038/s41572-020-00243-0 · 2021 · External reference

Tumour hypoxia in driving genomic instability and tumour evolution

2025 · External reference

Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: impact of image registration and acquisition type. Phys Imaging

2025 · External reference

Impact of geometric correction on echo-planar imaging-based apparent diffusion coefficient maps for abdominal radiotherapy

10.1088/2057-1976/ad7597 · 2024 · External reference

Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging

2024 · External reference

Focal boost to the Intraprostatic Tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III Trial

10.1200/jco.20.02873 · 2021 · External reference

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial

10.1136/bmjopen-2025-111791 · 2026 · External reference

Predictive utility of Post-Treatment tumor apparent diffusion coefficient in High-Risk prostate cancer undergoing definitive Radiotherapy: a Long-Term outcome analysis

10.1016/j.radonc.2025.111090 · 2025 · External reference